Skip to main content Accessibility help
×
Home
Hostname: page-component-5bf98f6d76-m4xc2 Total loading time: 14.892 Render date: 2021-04-21T11:22:38.426Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": false, "newCiteModal": false, "newCitedByModal": true }

Two Causes of Demyelinating Neuropathy in One Patient: CMT1A and POEMS Syndrome

Published online by Cambridge University Press:  02 December 2014

Nizar Chahin
Affiliation:
Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Steven R. Zeldenrust
Affiliation:
Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Kimberly K. Amrami
Affiliation:
Department of Hematology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
JaNean K. Engelstad
Affiliation:
Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
P. James
Affiliation:
Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
B. Dyck
Affiliation:
Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Rights & Permissions[Opens in a new window]

Abstract

Image of the first page of this article. For PDF version, please use the ‘Save PDF’ preceeding this image.
Type
Peer Reviewed Letter
Copyright
Copyright © The Canadian Journal of Neurological 2007

References

1. Birouk, N, Gouider, R, Le Guern, E, Gugenheim, M, Tardieu, S, Maisonobe, T, et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain. 1997;120(Pt 5):81323.CrossRefGoogle ScholarPubMed
2. Dyck, PJ, Dyck, PJB, Chalk, CH. The 10 P’s: A mnemonic helpful in characterization and differential diagnosis of peripheral neuropathy. Neurology. 1992;42:148.CrossRefGoogle ScholarPubMed
3. Dispenzieri, A, Kyle, RA, Lacy, MQ, Rajkumar, SV, Therneau, TM, Larson, DR, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101(7):2496506.CrossRefGoogle ScholarPubMed
4. Dispenzieri, A. POEMS Syndrome. Hematology (Am Soc Hematol Educ Program). 2005:3607.Google ScholarPubMed
5. Dyck, PJ, Sherman, WR, Hallcher, LM, Service, FJ, O’Brien, PC, Grina, LA, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980;8(6):5906.CrossRefGoogle ScholarPubMed
6. Lupski, JR, de Oca-Luna, RM, Slaugenhaupt, S, Pentao, L, Guzzetta, V, Trask, BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991;66:21932.CrossRefGoogle ScholarPubMed
7. Dyck, PJ, Swanson, CJ, Low, PA, Bartleson, JD, Lambert, EH. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc. 1982;57:23946.Google ScholarPubMed
8. Murakami, T, Oomori, H, Hara, A, Uyama, E, Mita, S, Uchino, M. Atypical phenotype of charcot-marie-tooth disease type 1A. Muscle Nerve. 1999;22(11):15936.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
9. Malandrini, A, Villanova, M, Dotti, MT, Federico, A. Acute inflammatory neuropathy in Charcot-Marie-Tooth disease. Neurology. 1999;52(4):85961.CrossRefGoogle ScholarPubMed
10. Gabriel, CM, Gregson, NA, Wood, NW, Hughes, RA. Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a). J Neurol Neurosurg Psychiatry. 2002;72(2):2305.CrossRefGoogle Scholar
11. Vital, A, Vital, C, Lagueny, A, Ferrer, X, Ribiere-Bachelier, C, Latour, P, et al. Inflammatory demyelination in a patient with CMT1A. Muscle Nerve. 2003;28(3):3736.CrossRefGoogle Scholar
12. Ginsberg, L, Malik, O, Kenton, AR, Sharp, D, Muddle, JR, Davis, MB, et al. Coexistent hereditary and inflammatory neuropathy. Brain. 2004;127(Pt 1):193202.CrossRefGoogle ScholarPubMed
13. Carvalho, AA, Vital, A, Ferrer, X, Latour, P, Lagueny, A, Brechenmacher, C, et al. Charcot-Marie-Tooth disease type 1A: clinicopathological correlations in 24 patients. J Peripher Nerv Syst. 2005;10(1):8592.CrossRefGoogle ScholarPubMed
14. Castleman, B, Towne, VW. Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot. N Engl J Med. 1954;251(10):396400.Google ScholarPubMed
15. Castleman, B, Iverson, L, Menendez, VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9(4):82230.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
16. Dispenzieri, A, Gertz, MA. Treatment of Castleman’s disease. Curr Treat Options Oncol. 2005;6(3):25566.CrossRefGoogle ScholarPubMed
17. Keller, AR, Hochholzer, L, Castleman, B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29(3):67083.3.0.CO;2-#>CrossRefGoogle ScholarPubMed
18. Mallory, A, Spink, WW. Angiomatous lymphoid hamartoma in the retroperitoneum presenting with neurologic signs in the legs. Ann Intern Med. 1968;69(2):3058.CrossRefGoogle ScholarPubMed
19. Donaghy, M, Hall, P, Gawler, J, Gregson, NA, Leibowitz, S, Jitpimolmard, S, et al. Peripheral neuropathy associated with Castleman’s disease. J Neurol Sci. 1989;89(2-3):25367.CrossRefGoogle ScholarPubMed
20. Watanabe, O, Arimura, K, Kitajima, I, Osame, M, Maruyama, I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet. 1996;347:702.CrossRefGoogle Scholar
21. Soubrier, M, Dubost, JJ, Serre, AF, Ristori, JM, Sauvezie, B, Cathebras, P, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum. 1997;40(4):7867.CrossRefGoogle ScholarPubMed
22. Watanabe, O, Maruyama, I, Arimura, K, Kitajima, I, Arimura, H, Hanatani, M, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve. 1998;21(11):13907.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
23. Dyck, PJ, Engelstad, J, Dispenzieri, A. Vascular endothelial growth factor and POEMS. Neurology. 2006;66(1):102.CrossRefGoogle ScholarPubMed
24. Nishi, J, Arimura, K, Utsunomiya, A, Yonezawa, S, Kawakami, K, Maeno, N, et al. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman’s disease. Br J Haematol. 1999;104(3):4825.CrossRefGoogle ScholarPubMed
25. Nishi, J, Maruyama, I. Increased expression of vascular endothelial growth factor (VEGF) in Castleman’s disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Leuk Lymphoma. 2000;38(3-4):38794.CrossRefGoogle ScholarPubMed
26. Scarlato, M, Previtali, SC, Carpo, M, Pareyson, D, Briani, C, Del Bo, R, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain. 2005;128:191120.CrossRefGoogle ScholarPubMed
27. Jaccard, A, Royer, B, Bordessoule, D, Brouet, JC, Fermand, JP. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood. 2002;99(8):30579.CrossRefGoogle ScholarPubMed
28. Dispenzieri, A, Moreno-Aspitia, A, Suarez, GA, Lacy, MQ, Colon-Otero, G, Tefferi, A, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood. 2004;104(10):34007.CrossRefGoogle Scholar
29. Dispenzieri, A, Gertz, MA. Treatment options for POEMS syndrome. Expert Opin Pharmacother. 2005;6(6):94553.CrossRefGoogle ScholarPubMed
30. Kuwabara, S, Misawa, S, Kanai, K, Kikkawa, Y, Nishimura, M, Nakaseko, C, et al. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology. 2006;66(1):1057.CrossRefGoogle ScholarPubMed
31. Straume, O, Bergheim, J, Ernst, P. Bevacizumab therapy for POEMS syndrome. Blood. 2006;107(12):49723; author reply 3-4.CrossRefGoogle ScholarPubMed

Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 0
Total number of PDF views: 129 *
View data table for this chart

* Views captured on Cambridge Core between September 2016 - 21st April 2021. This data will be updated every 24 hours.

You have Access

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Two Causes of Demyelinating Neuropathy in One Patient: CMT1A and POEMS Syndrome
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Two Causes of Demyelinating Neuropathy in One Patient: CMT1A and POEMS Syndrome
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Two Causes of Demyelinating Neuropathy in One Patient: CMT1A and POEMS Syndrome
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *